|
Title
|
|
|
|
Price tag in nanomaterials?
|
|
|
Author
|
|
|
|
|
|
|
Abstract
|
|
|
|
| With the evolution of the field of nanomaterials in the past number of years, it has become apparent that it will be key to future technological developments. However, while there are unlimited research undertakings on nanomaterials, limited research results on nanomaterial costs exist; all in spite of the generous funding that nanotechnology projects have received. There has recently been an exponential increase in the number of studies concerning health-related nanomaterials, considering the various medical applications of nanomaterials that drive medical innovation. This work aims to analyze the effect of the cost factor on acceptability of health-related nanomaterials independently or in relation to material toxicity. It appears that, from the materials studied, those used for cancer treatment applications are more expensive than the ones for drug delivery. The ability to evaluate cost implications improves the ability to undertake research mapping and develop opinions on nanomaterials that can drive innovation. |
|
|
|
Language
|
|
|
|
English
|
|
|
Source (journal)
|
|
|
|
Journal of nanoparticle research. - London, 1999, currens
|
|
|
Publication
|
|
|
|
London
:
2017
|
|
|
ISSN
|
|
|
|
1388-0764
[print]
1572-896X
[online]
|
|
|
DOI
|
|
|
|
10.1007/S11051-017-3875-X
|
|
|
Volume/pages
|
|
|
|
19
:5
(2017)
, p. 1-7
|
|
|
Article Reference
|
|
|
|
177
|
|
|
ISI
|
|
|
|
000411830900001
|
|
|
Medium
|
|
|
|
E-only publicatie
|
|
|
Full text (Publisher's DOI)
|
|
|
|
|
|
|
Full text (open access)
|
|
|
|
|
|
|
Full text (publisher's version - intranet only)
|
|
|
|
|
|